Annual Net Income
-$4.62 M
-$2.02 M-77.81%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual net profit is currently -$4.62 million, with the most recent change of -$2.02 million (-77.81%) on 01 December 2023. During the last 3 years, it has fallen by -$4.56 million (-7386.22%). LIPO annual net income is now -7386.22% below its all-time high of -$61.70 thousand, reached on 01 December 2020.LIPO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.44 M
-$506.50 K-53.99%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly net profit is currently -$1.44 million, with the most recent change of -$506.50 thousand (-53.99%) on 01 September 2024. Over the past year, it has dropped by -$755.70 thousand (-109.70%). LIPO quarterly net income is now -322.89% below its all-time high of -$341.60 thousand, reached on 01 June 2021.LIPO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$4.26 M
-$121.00 K-2.92%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM net profit is currently -$4.26 million, with the most recent change of -$121.00 thousand (-2.92%) on 01 September 2024. Over the past year, it has increased by +$355.60 thousand (+7.70%). LIPO TTM net income is now -593.69% below its all-time high of -$614.60 thousand, reached on 01 March 2021.LIPO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -109.7% | +7.7% |
| 3 y3 years | -7386.2% | -275.5% | -128.5% |
| 5 y5 years | - | - | - |
LIPO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7386.2% | at low | -297.0% | +6.1% | -128.5% | +10.1% |
| 5 y | 5 years | -7386.2% | at low | -322.9% | +6.1% | -593.7% | +10.1% |
| alltime | all time | -7386.2% | at low | -322.9% | +6.1% | -593.7% | +10.1% |
Lipella Pharmaceuticals Common Stock Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.44 M(+54.0%) | -$4.26 M(+2.9%) |
| June 2024 | - | -$938.10 K(-21.3%) | -$4.14 M(-12.7%) |
| Mar 2024 | - | -$1.19 M(+73.0%) | -$4.74 M(+2.7%) |
| Dec 2023 | -$4.62 M(+77.8%) | -$688.90 K(-48.0%) | -$4.62 M(+7.6%) |
| Sept 2023 | - | -$1.32 M(-14.0%) | -$4.29 M(+16.6%) |
| June 2023 | - | -$1.54 M(+44.1%) | -$3.68 M(+25.8%) |
| Mar 2023 | - | -$1.07 M(+193.4%) | -$2.93 M(+12.7%) |
| Dec 2022 | -$2.60 M | -$363.90 K(-49.0%) | -$2.60 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$713.80 K(-8.7%) | -$2.62 M(+7.8%) |
| June 2022 | - | -$782.00 K(+6.0%) | -$2.43 M(+22.1%) |
| Mar 2022 | - | -$737.90 K(+91.8%) | -$1.99 M(+6.6%) |
| Dec 2021 | -$1.87 M(+2923.5%) | - | - |
| Dec 2021 | - | -$384.70 K(-26.7%) | -$1.87 M(+26.0%) |
| Sept 2021 | - | -$524.60 K(+53.6%) | -$1.48 M(+54.9%) |
| June 2021 | - | -$341.60 K(-44.4%) | -$956.20 K(+55.6%) |
| Mar 2021 | - | -$614.60 K | -$614.60 K |
| Dec 2020 | -$61.70 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual net profit?
- What is the all time high annual net income for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly net profit?
- What is the all time high quarterly net income for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly net income year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM net profit?
- What is the all time high TTM net income for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM net income year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual net profit?
The current annual net income of LIPO is -$4.62 M
What is the all time high annual net income for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual net profit is -$61.70 K
What is Lipella Pharmaceuticals Common Stock quarterly net profit?
The current quarterly net income of LIPO is -$1.44 M
What is the all time high quarterly net income for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly net profit is -$341.60 K
What is Lipella Pharmaceuticals Common Stock quarterly net income year-on-year change?
Over the past year, LIPO quarterly net profit has changed by -$755.70 K (-109.70%)
What is Lipella Pharmaceuticals Common Stock TTM net profit?
The current TTM net income of LIPO is -$4.26 M
What is the all time high TTM net income for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM net profit is -$614.60 K
What is Lipella Pharmaceuticals Common Stock TTM net income year-on-year change?
Over the past year, LIPO TTM net profit has changed by +$355.60 K (+7.70%)